Zomedica Corp (ZOMDF) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

fourth quarter 2024 financial results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, March 13th, 2025. I would now like to turn the conference over to Mr. Mike Valli from ICR. Please go ahead. Thank you, Operator, and good afternoon, ladies and gentlemen. Welcome to Zamedica's fourth quarter 2024 earnings results and business update call. Joining me on today's call are Zamedica's Chief Executive Officer, Larry Heaton, Scott Jordan, the company's new Executive Vice President and Chief Financial Officer, and Mike Zelke, Vice President and Corporate Controller. Before we begin, we would like to remind everyone that on this call, we will be making various remarks about future expectations plans and prospects that constitute forward-looking statements. These forward-looking statements are based on assumptions, and there are risks that the results may differ materially from those statements. As such, Zomedica cannot guarantee that any forward-looking statements will materialize, and you are cautioned not to place undue reliance on them. We refer current and potential investors to the forward-looking information and risk factors sections of our public filings available on CDARplus at www.cdarplus.ca and on EDGAR at sec.gov. Forward-looking statements made on this conference call represents Zomedica's expectations as of today, March 13, 2025. I will now pass the call over to Zomedica's Chief Executive Officer, Larry Heaton. Larry? Thanks, Mike. I'd like to start by thanking our shareholders for your support. Wishing prospective investors...